ATX 3.33% 14.5¢ amplia therapeutics limited

Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,136 Posts.
    lightbulb Created with Sketch. 668
    Absolutely great news

    Having approval such as this, one could Imagine it will simplify the process when FDA approval is required in America. As we position ourselves with narmafotinib to be the preferred drug to tackle pancreatic cancer.
    The largest healthcare market in the world.


    I’m surprised you still buy 8.1 cents …. incredible


    .
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.